Biogen, Inc. (NQ: BIIB )

300.19 USD UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist

Price and Volume

Volume	1,284
Open	300.19
Bid (Size)	297.00 (2)
Ask (Size)	298.98 (1)
Prev. Close	300.19
Today's Range	300.19 - 300.19
52wk Range	223.25 - 468.35
Shares Outstanding	149,033,443
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab-nuna)

Today 7:30 EDT

FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab-nuna)

Today 7:30 EDT

Performance

YTD	+23.56%	+23.56%
1 Month	-12.16%	-12.16%
3 Month	-21.19%	-21.19%
6 Month	+10.23%	+10.23%
1 Year	+11.89%	+11.89%

More News

CHMP Recommends VUMERITY® (diroximel fumarate) for Approval in the European Union as a Treatment for Relapsing-Remitting Multiple Sclerosis

September 17, 2021

Biogen Announces Positive Topline Results from Phase 2 CONVEY Study in Small Fiber Neuropathy

September 16, 2021

Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi® (risdiplam)

September 15, 2021

Notable Friday Option Activity: FE, BIIB, SIVB

September 17, 2021

Expert Ratings For Biogen

September 16, 2021

Biogen Reports Mixed Phase 2 Data For Its Non-Opioid Pain Candidate

September 16, 2021

With Prothena Up Over 500% This Year, Is It Too Late to Get in?

September 18, 2021

Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know

September 15, 2021

First Week of BIIB September 17th Options Trading

September 15, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

Mammoth Times

Biogen, Inc. (NQ: BIIB )

Price and Volume

Top News

Performance

More News